Generated by GPT-5-mini| Disclosure | |
|---|---|
| Name | Disclosure |
| Type | Concept |
| Fields | Law; Business; Medicine; Science; Media |
Disclosure Disclosure is the act of revealing information to others, often involving confidentiality tensions, transparency goals, and accountability demands. It encompasses legal, ethical, and practical procedures across corporate governance, clinical trials, academic publishing, freedom of information legislation, and journalism practices. Stakeholders include regulators, practitioners, institutions, and the public in contexts such as securities regulation, medical ethics, data protection, and international treaties.
This section defines mandatory, voluntary, and selective forms found in contexts such as securities regulation, informed consent, freedom of information legislation, whistleblowing, and corporate reporting. Types include financial disclosure in initial public offering processes and annual report filings, clinical disclosure in randomized controlled trial reporting and Institutional Review Board submissions, and personal data disclosure under General Data Protection Regulation frameworks. Other modalities appear in classified-information declassification processes like those overseen by National Archives and Records Administration and in disclosure obligations arising from Freedom of Information Act requests. Distinctions are often drawn between full disclosure, partial disclosure, retroactive disclosure, and controlled disclosure in contexts such as merger and acquisition negotiations, litigation discovery, and regulatory compliance audits.
Legal regimes governing disclosure include statutes and rules such as Securities Exchange Act of 1934, Health Insurance Portability and Accountability Act, General Data Protection Regulation, and national freedom of information laws like the Freedom of Information Act (United States). Regulatory bodies imposing disclosure duties include Securities and Exchange Commission, Food and Drug Administration, European Medicines Agency, Financial Conduct Authority, and International Accounting Standards Board. International instruments and treaties can require disclosure in areas such as anti-corruption enforcement under United Nations Convention against Corruption and Basel Committee on Banking Supervision standards. Litigation-driven disclosure follows procedural rules exemplified by Federal Rules of Civil Procedure discovery obligations and evidentiary standards in European Court of Human Rights jurisprudence.
Ethical frameworks address conflicts between disclosure obligations and duties such as confidentiality owed under Hippocratic Oath, professional codes like those of American Medical Association and American Bar Association, and institutional ethics committees including Institutional Review Board oversight. Debates involve balancing individual autonomy in informed consent procedures with public interest in transparency promoted by Open Government Partnership initiatives. Ethical dilemmas arise in contexts such as whistleblower protection under Whistleblower Protection Act, disclosures implicating national security handled by Intelligence Community oversight, and publication ethics guided by organizations like the Committee on Publication Ethics.
Finance: Best practices for disclosures in initial public offering prospectuses, quarterly earnings reports, and proxy statement filings are enforced by bodies such as the Securities and Exchange Commission and embodied in standards from the International Financial Reporting Standards Foundation.
Healthcare: Clinical trial registries and reporting requirements under organizations like the World Health Organization and ClinicalTrials.gov shape disclosure of trial protocols, adverse events, and outcomes; medical publications follow guidance from International Committee of Medical Journal Editors.
Science and Academia: Open data and open methodology norms promoted by National Institutes of Health, European Commission research programs, and repositories like arXiv influence disclosure of materials, code, and negative results.
Technology and Data Protection: Personal data disclosures are governed by frameworks such as the General Data Protection Regulation, enforced by national supervisory authorities like the Information Commissioner's Office.
Media and Journalism: Source protection versus public interest disclosure is navigated through standards from organizations like the Society of Professional Journalists and case law from institutions such as the Supreme Court of the United States.
Government and International Affairs: Declassification schedules, transparency commitments in Freedom of Information Act (United States), and treaty reporting obligations to bodies such as the United Nations define state-level disclosure practices.
Disclosure practices affect market efficiency, public trust, and accountability, as evidenced by reforms following events like the Enron scandal and regulatory responses such as the Sarbanes–Oxley Act. In healthcare, improved disclosure can enhance patient safety and evidence synthesis in systematic review processes overseen by organizations like the Cochrane Collaboration. Transparency initiatives under Open Government Partnership have measurable effects on corruption indices maintained by Transparency International. Scientific reproducibility benefits from disclosure policies advocated by the National Academies of Sciences, Engineering, and Medicine and implemented by publishers like Nature Publishing Group and Elsevier.
Critiques address excessive disclosure leading to information overload, strategic withholding in insider trading contexts, and privacy harms under inadequate redaction despite rules like the Health Insurance Portability and Accountability Act. Tensions exist between disclosure and national security as litigated before bodies such as the European Court of Human Rights and adjudicated by entities including the Foreign Intelligence Surveillance Court. Additional challenges include uneven enforcement across jurisdictions represented by agencies like the Financial Conduct Authority versus weaker regulators, and perverse incentives illustrated by scandals like Cambridge Analytica that highlight limits of disclosure alone to prevent misuse.
Category:Information policy